Applications of different types of technologies are critical for many of our products. Three of our products were developed using the SoluMatrix® Technology which reduces the drug particle sizes resulting in nonsteroidal products to be quickly dissolved and rapidly absorbed. Our abuse-discouraging opioid was developed using the Aversion® Technology which was designed to discourage nasal abuse. Using our proprietary Guardian technology, we have been able to design tablets with controlled-release profiles as well as physical and chemical properties to resist both common and rigorous methods of manipulation. Our technology was used to develop products which are in various stages of development in our pipeline.